Humanigen Inc HGEN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:40 AM EDT
20.24quote price arrow down-0.28 (-1.37%)
Volume
115,787
52 week range
7.50 - 33.95

...

Loading . . .
  • Open20.66
  • Day High21.00
  • Day Low20.13
  • Prev Close20.52
  • 52 Week High33.95
  • 52 Week High Date07/28/20
  • 52 Week Low7.50
  • 52 Week Low Date09/10/20

Key Stats

  • Market Cap1.196B
  • Shares Out59.08M
  • 10 Day Average Volume1.17M
  • Dividend-
  • Dividend Yield-
  • Beta-2.35
  • YTD % Change16.57

KEY STATS

  • Open20.66
  • Day High21.00
  • Day Low20.13
  • Prev Close20.52
  • 52 Week High33.95
  • 52 Week High Date07/28/20
  • 52 Week Low7.50
  • 52 Week Low Date09/10/20
  • Market Cap1.196B
  • Shares Out59.08M
  • 10 Day Average Volume1.17M
  • Dividend-
  • Dividend Yield-
  • Beta-2.35
  • YTD % Change16.57

RATIOS/PROFITABILITY

  • EPS (TTM)-3.36
  • P/E (TTM)-6.02
  • Fwd P/E (NTM)6.09
  • EBITDA (MRQ)-150.537M
  • ROE (MRQ)-41,589.92%
  • Revenue (MRQ)800,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-19,127.19%
  • Debt To Equity (MRQ)143.59%

EVENTS

  • Earnings Date08/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Humanigen Inc

There is no recent news for this security.

Profile

MORE
Humanigen, Inc., formerly KaloBios Pharmaceuticals, Inc., is a biopharmaceutical company. The Company focuses on developing medicines for patients with neglected and rare diseases, with an ancillary focus on pediatric conditions. The Company's product candidate is benznidazole for the treatment of Chagas disease, a parasitic illness that can lead to long-term heart, intestinal and neurological problems. It is engaged in developing monoclonal antibodies, lenzilumab, for the...
Cameron Durrant M.D.
Chairman
Timothy Morris
Chief Financial Officer
Address
533 Airport Blvd Ste 400
Burlingame, CA
94010-2013
United States

Top Peers

SYMBOLLASTCHG%CHG
PCVX
Vaxcyte Inc
22.24-0.73-3.18%
CYDY
Cytodyn Inc
1.77-0.07-3.61%
AVXL
Anavex Life Sciences Corp
17.97-3.02-14.37%
FMTX
Forma Therapeutics Holdings Inc
24.32+0.06+0.25%
KROS
Keros Therapeutics Inc
51.78-1.11-2.10%